小儿急性白血病细胞DNA、蛋白质含量及其临床意义

用流式细胞术（ＦＣＭ）测定了４５例不同病期急性白血病患儿和１３例非白血病患儿骨髓细胞ＤＮＡ及蛋白质含量,结果显示：１．急性白血病患儿的ＤＮＡ非整倍体检出率为４１．２％,其中ＡＬＬ为３３．３％,ＡＮＬＬ为６０％;２．ＡＬＬ组和ＡＮＬＬ组的ＤＮＡ合成期细胞百分数（Ｓ％）显著低于非白血病组,而ＣＲ组与非白血病组之间的Ｓ％差异无显著性;３．ＡＮＬＬ组的ＰｒＩ显著高于ＡＬＬ组、非白血病组及ＣＲ组,ＡＬＬ的ＰｒＩ显著低于ＣＲ组和非白血病组,而非白血病组与ＣＲ组的ＰｒＩ差异无显著性。四组之间ＬＰＣ－Ｆ差异无显著性;４．在对１１例ＣＲ病人进行的连续观察过程中,５例病人检出ＤＮＡ非整信体,其中４例于检出ＤＮＡ非整倍体后３３～７４天复发。     

多叶猴耳环──猴耳环属一新种

多叶猴耳环──猴耳环属一新种文和群（广西植物研究所分类研究室,桂林５４１００６）ＰＩＴＨＥＣＥＬＬＯＢＩＵＭＭＵＬＴＩＦＯＬＩＯＬＡＴＵＭ－ＡＮＥＷＳＰＥＣＩＥＳＯＦＰＩＴＨＥＣＥＬＬＯＢＩＵＭＦＲＯＭＧＵＡＮＧＸＩ,ＣＨＩＮＡＷｅｎＨｅｑｕｎ（Ｇｕ...     

不同光质对毛地黄愈伤组织诱导和增殖的效应

不同光质对毛地黄愈伤组织诱导和增殖的效应毛学文陈荃（天水师范高等专科学校生物系,天水７４１０００）ＥＦＦＥＣＴＳＯＦＬＩＧＨＴＱＵＡＬＩＴＹＯＮＣＡＬＬＵＳＩＮＤＵＣＴＩＯＮＡＮＤＧＲＯＷＴＨＯＦＤＩＧＩＴＡＬＳＰＵＲＰＵＲＥＡＭａｏＸｕｅ－ｗｅｎＣ...     

达乌尔黄鼠染色体银染核仁组织者分析

达乌尔黄鼠染色体银染核仁组织者分析ＡＮＡＬＹＳＩＳＯＮＣＨＲＯＭＯＳＯＭＥＳＡｇ－ＮＯＲＳＯＦＣＩＴＥＬＬＵＳＤＡＵＲＩＣＵＳＫｅｙｗｏｒｄｓＣｉｌｅｌｌｕｓｄａｕｒｉｃｕｓ;Ｃｈｒｏｍｏｓｏｍｅ;Ａｇ－ＮＯＲ达乌尔黄鼠（ｃｉｌｅｌｌｕｓｄａｕｒｉｃ...     

ATP对巨噬细胞内吞和溶酶体pH的影响

ＦＩＴＣ－ｄｅｘｔｒａｎ标记培养的小鼠腹腔巨噬细胞溶酶体,ＣｏｎＡ－ＦＩＴＣ标记细胞内吞。用激光扫描共聚焦显微镜测量伴刀豆球蛋白（ＣｏｎＡ）、ＡＴＰ引起的巨噬细胞溶酶体ｐＨ动态变化和ＡＴＰ对细胞内吞ＣｏｎＡ－ＦＩＴＣ的影响。结果显示ＣｏｎＡ引起巨噬细胞溶酶体ｐＨ迅速增加,６ｍｉｎ左右达到峰值（ｐＨ５．７）;ＡＴＰ刺激３０ｍｉｎ后再加入ＣｏｎＡ,溶酶体ｐＨ无明显变化（ｐＨ４．０）;同时加入ＡＴＰ和ＣｏｎＡ,５ｍｉｎ左右溶酶体ｐＨ降到最低点（ｐＨ４．１）;ＡＴＰ对巨噬细胞内吞ＣｏｎＡ－ＦＩＴＣ有明显的抑制作用。探讨了受体介导内吞与溶酶体ｐＨ的关系。     

DAKO-M1在胃癌组织表达的免疫组织化学研究

对９５例胃癌组织进行ＤＡＫＯ－Ｍ１（ＤＡＫＯ－ＣＤ１５）表达的免疫组织化学研究。结果发现,ＤＡＫＯ－Ｍ１在胃癌中的阳性率（８６．３％）显著高于癌旁粘膜和正常胃粘膜（Ｐ＜０．０５和０．００５）。其定位分布有３种类型：即腺腔缘型（Ａ型）、胞膜型（Ｍ型）和胞浆型（Ｃ型）。胃非肿瘤性粘膜组织仅为Ａ型。胃癌３型兼有,高分化癌Ａ型（１８．２％）和Ｍ型（６１．４％）均显著高于低分化癌（Ｐ值均＜０．００５）;低分化癌和粘液癌Ｃ型（各占７２．０％和５３．８％）均显著高于高分化癌（２０．５％）,Ｐ＜０．００５和０．０２５。ＤＡＫＯ－Ｍ１Ｃ型和Ｍ型淋巴结转移率（分别为９７．１％和６９．２％）均显著高于Ａ型（３３．３％）者,Ｐ＜０．００５和０．０５。结果提示,ＤＡＫＯ－Ｍ１是判断胃癌分化水平、恶性程度及预测淋巴结转移的一种有用标志物     

中国苋属nrDNA的ITS序列分析及其系统学意义

运用ＰＣＲ直接测序法,对苋属（Ａｍａｒａｎｒｈｕｓ Ｌ．）１５个种及外类群鸡冠花（Ｃｅｌｏｓｉａ ｃｒｉｓｔａｔａ Ｌ．）ｎｒＤＮＡ的ＩＴＳ区（包括ＩＴＳ－１,５．８５ｒＤＮＡ和ＩＴＳ－２）进行序列测定。结果表明苋属植物的ＩＴＳ序列总长度为６２９－６３２ｂｐ,长度变异仅发生在ＩＴＳ－１区（２５０－２５３ｂｐ）。采用ＰＡＵＰ软件进行系统发育分析表明：分布于中国的苋属植物可分为３组,即刺苋组（ｓｅｃｇ     

中国新记录属——疣叶苔属及其一新种

中国新记录属———疣叶苔属及其一新种衣艳君刘家尧高谦（曲阜师范大学生物系山东曲阜２７３１６５）（中国科学院沈阳应用生态研究所沈阳１１００１５）ＨＯＲＩＫＡＷＡＥＬＬＡ（ＨＥＰＡＴＩＣＡＥ）,ＮＥＷＴＯＣＨＩＮＡＷＩＴＨＡＮＥＷＳＰＥＣＩＥＳＦＲＯＭＹ...     

巨噬细胞细胞内吞过程中膜受体流动性的测量——两种标记受体…

本文首次实现了细胞内吞过程中膜受体流动性的测量。实验选择巨噬细胞膜和伴刀豆凝集素Ａ（ＣｏｎＡ）。分别用ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩＴＣ（ＡＢＣ法）和ＣｏｎＡ－ＦＩＴＣ（直接法）两种方法标记巨哓细胞膜ＣｏｎＡ受体，比较了这两咱方法标记的巨噬细胞ＣｏｎＡ受体的荧光强度，利用ＦＲＡＰ技术。分别用两种标记方法测量了巨细胞ＣｏｎＡ受体的流动性。结果显示ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩ     

测量细胞内吞过程中膜受体流动性的新方法

本文首次提出用ＡＢＣ（ＡｖｉｄｉｎＢｉｏｔｉｎＣｏｍｐｌｅｘ）法标记细胞膜受体,通过ＦＲＡＰ（ＦｌｕｏｒｅｓｃｅｎｃｅＲｅｃｏｖｅｒｙＡｆｔｅｒＰｈｏｔｏｂｌｅａｃｈｉｎｇ）技术,测量细胞内吞过程中受体流动性变化的方法。实验选择巨噬细胞ＣｏｎＡ受体,比较了用ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩＴＣ（ＡＢＣ法）和ＣｏｎＡ－ＦＩＴＣ（直接法）标记的膜表面ＣｏｎＡ受体荧光强度和内吞过程中受体的流动性测量结果。结果显示ＣｏｎＡ－Ｂｉｏｔｉｎ＋Ａｖｉｄｉｎ－ＦＩＴＣ标记的巨噬细胞膜受体的平均荧光强度比用ＣｏｎＡ－ＦＩＴＣ标记的平均荧光强度高大约３倍;ＡＢＣ法标记的受体,测量结果误差小、灵敏度高;ＣｏｎＡ刺激１５ｍｉｎ后,巨噬细胞膜表面ＣｏｎＡ受体的扩散系数和荧光恢复率较静息状态时明显下降。讨论了两种标记方法对测量结果的影响     

Chromosomes in acute leukemia

Summary The karyotype of leukemic cells of 78 acute leukemia patients (37 ANLL, 34ALL, and 7 of unknown type) was studied by means of G-banding. Chromsomal abnormalities were found in 50 patients (72%). Chromosomes 8, 21, 5, 7, 11, and 19 were preferentially involeved in the abnormalities, both in ANLL and in ALL. A high incidence of the characteristic rearrangement t(8,21) was noted in AML: (in 6 of 22 AML patients). An identical reciprocal translocation—t(4;11)—was seen in 4 out of 34 ALL patients.     

In vitro culture studies of granulocyte/macrophage and erythroid progenitor cells in lymphoproliferative disorders

Granulocyte/macrophage progenitor cells (CFU-GM) and erythroid progenitor cells (BFU-E) have been assayed in peripheral blood (PB) and/or bone marrow (BM) from 12 patients with acute lymphocytic leukemia (ALL), 16 patients with chronic lymphocytic leukemia (CLL) and 31 patients with various forms of non-Hodgkin lymphoma (NHL) without BM involvement. Progenitor cell growth in PB and BM from the NHL patients did not differ statistically from controls (p greater than 0.1). CFU-GM and BFU-E per ml PB were markedly increased in ALL and CLL patients (p less than 0.001) while CFU-GM and BFU-E per plated BM cells from these patients were severely depressed (p less than 0.001). Lymphoblasts from one ALL patient failed to inhibit CFU-GM and BFU-E-derived colony growth from control PB mononuclear cells. The high levels of circulating progenitor cells in ALL and CLL patients clearly distinguish them from other cytopenic hematological malignancies, in which decreased progenitor cell levels have been demonstrated previously (acute myeloid leukemia, hairy cell leukemia). The cause of this finding and its pathophysiological implication still remains to be established.     

Cytogenetics and cytochemistry of leukemia patients in 2 neotropical hospitals

A cytogenetic and/or cytochemical study was performed in 166 individuals with leukemia or related disorders, in two major Costa Rican hospitals. In those patients treated at an adult's hospital (14 years old and over), acute leukemias represented 66% of all cases. In that hospital the most frequent types of disorders were, in decreasing order: ANLL (> M1), ALL, CML (all of them showed the Ph chromosome) and MDS. In the cases from a childrens' hospital (< 14 years old) acute leukemias were 98%. Among them the order of frequency was: ALL (70%): ALL-1 (84%), ALL-2 (16%) and ANLL (27%): M5a > M3 > M4 > M5b. In ALL 85% were type B and occurred mostly in women while 15% of them were type T and more frequent in males. There was 5.6% infant leukemia, which presented a similar number of acute lymphoids and myeloids. The cytogenetic pattern was similar among Costa Rica and other tropical and temperate countries.     

Clinical significance of fibrinopeptide A in acute lymphocytic and non-lymphocytic leukaemia

Fibrinopeptide A (FPA) was systematically investigated in 74 patients with acute leukaemia at different stages of the disease (50 with non-lymphocytic leukaemia, ANLL; 24 with lymphocytic leukaemia, ALL). At diagnosis, 75% of the cases had high FPA levels (86% in ANLL and 54% in ALL) with significantly higher levels in ANLL than in ALL (13.4 vs 4.4 ng/ml; p less than 0.001). Patients with DIC (20 cases in ANLL and 1 case in ALL) had significantly higher levels (p less than 0.001). FPA levels were neither correlated with fibrinogen or FDP levels nor with blast cell count. During chemotherapy, median FPA did not show significant changes whereas, at the end of therapy, a return toward normality was generally observed both in ALL and ANLL apart from the group of patients with acute promyelocytic leukaemia. Among the 24 patients who entered post-remission follow-up (13 ANLL and 11 ALL), 10 cases out of the 11 relapsing (6/6 with ANLL and 4/5 with ALL) had increased FPA 1 to 2 months before the ascertainment of the relapse. However, 16% and 9% of the samples obtained on different occasions, respectively from ANLL and ALL cases in maintained first remission, showed FPA above the normal limit. This study demonstrates that subclinical activation of blood coagulation, as indicated by high FPA level, is common both in lymphocytic and non-lymphocytic leukemia and suggests that this phenomenon is related to disease activity.     

‘Conservative’ and ‘variable’ clusters of Alu-family DNA repeats in human chromosomes

The distribution of Alu-family DNA repeats (AFRs) in chromosomes of phytohaemagglutinin-stimulated peripheral blood lymphocytes of four normal donors and non-stimulated bone marrow cells of four patients with acute leukemia (ALL and ANLL) was studied by in situ hybridization using DNA of recombinant phage lambda containing multiple inserts of AFR as a probe. Over some chromosome bands (14cen, 16p13, 16cen) from normal donors and from leukemic patients clusters of silver grains were detected. Over other three bands (3q26, 8p11-p12 and 14q24) the clusters were found only in chromosomes from the four acute leukemia patients, and were absent from chromosomes of healthy donors. The results suggest non-random long-range distribution of AFRs in human chromosomes, and somatic variations in the distribution of the repeats.     

Chromosome 11 rearrangements in the different haematological neoplasias

The cases of chromosome 11 abnormalities in leukemic bone marrow cells have constituted 14.0% in acute lymphoblastic leukemia (ALL), 18.7% in acute myeloid leukemia (AML), and 16.7% in refractory anemia (RA). The bands of the short arms 11p13, 11p14, llp15 and the long arms 11q14, 11q21, 11q23 were involved in chromosome rearrangements. The rearrangements of the band 11q23 were detected more often. Reciprocal translocations were found with the highest frequency, while para- and pericentic invertions, terminal and intestitial deletions occured with the lower incidence. Deletions were found in RA cases only. Comparison with the clinical features showed no correlation with the age and the main haematological indexes including the amount of blast cells in the initial period. The results have showed the poor prognosis of the abnormalities not only of 11q21, 11q23 in acute leukemia (AL), but of 11p13, 11p15 in AML as well, while not enough data on this subject is availalbe in the literature.     

Rearrangements of chromosome 9 in different hematological neoplasias

In the present article the frequency of anomalies in chromosome 9 among children with hematological neoplasias amounted to 25/112 in acute lymphoblastic leukemia (ALL), 10/83 in acute myeloid leukemia (AML), and 3/20 in myelodysplastic syndrome (MDS). In ALL, deletions are encountered more often than translocations. Deletions are found in both single anomalies and as an element in complex karyotypes. The rearrangements involve the bands 9q34 and 9q22 the most often. The translocation t(9;22)(q34; q11) is encountered in 7.1% of all cases of ALL. In AML, translocation are found more often than deletions. Structural rearrangements most often involved the long arm, at bands 9q22 and 9q34. Deletions, duplications, and translocations were recorded in MDS. No relationship with the initial hematological indicators, including blastosis, were found. The studies attest to different directions of the clinical prognosis in the course of acute leukemia (AL) where there are deletions. Multidrug resistance and the continuing progress of the disease in the course of chemotherapy is found in t(9;22)(q34; q11).     

Detection of minimal residual disease (MRD) after bone marrow transplantation (BMT) by multi-parameter flow cytometry (MPFC)

Multi-parameter flow cytometry (MPFC) was used to detect minimal residual disease (MRD) following bone marrow transplantation (BMT) in 21 patients. Bone marrow (BM) was analyzed pre-transplant and 3–4 months post-BMT while the patients were in clinical and morphological remission. MRD was detected by identifying cells with aberrant antigen expression and/or leukemia-associated phenotype (LAP) using MPFC. Prior to BMT, 8 out of 21 patients exhibited normal antigen expression based on normal BM samples while 13 BM aspirates had abnormal MPFC. Pre-BMT MPFC was abnormal in all 10 patients who were not in complete remission (CR) (>5% blasts in BM) as well as 3 patients acute lymphoblastic leukemia (ALL) who were in CR. In BM from ALL patients, an abnormal uniform B cell population was observed however antigen expression patterns varied greatly between patients. BM from acute myeloblastic leukemia (AML) patients showed an abnormal distribution of CD34+ cells. In addition, a correlation was observed between pre-BMT cytogenetics and MPFC. Only 2 out of 8 (25%) patients with normal MPFC pre-autologous bone marrow transplantation (ABMT) relapsed (AML), while 6 out of 13 (46%) patients with abnormal pre-BMT MPFC relapsed including 2 out of 3 patients who were transplanted in clinical CR. Pre-BMT MPFC may thus be an effective tool for detection of MRD by detection of a pre-transplant MPFC abnormality.     

Cytogenetic analysis and clinical significance of chromosome 7 aberrations in acute leukaemia

The analysis was performed on bone marrow cells derived from 96 patients with acute leukaemia (AL): 76 with acute myelogenous leukaemia (AML) and 20 with acute lymphoblastic leukaemia (ALL). Aberrations of chromosome 7 were revealed in 20 (21%) of 96 analysed cases: in 14 (18%) with AML and in six (30%) with ALL. Structural aberrations, present in 13 patients (eight with AML and five with ALL), were unbalanced and led to partial monosomy (12 cases) or trisomy (four cases) of chromosome 7. Twelve (86%) out of 14 AML and all the ALL patients with chromosome 7 aberrations had complex karyotypes in their bone marrow cells. Monosomy 7 and 7q losses were frequently observed in the AML group, whereas, in the ALL group, gains in 7q and losses in the short arms constituted most chromosome 7 aberrations. The occurrence of monosomy, or of losses in 7q, results in a worse response to induction therapy in AML patients. The complete remission (CR) rate was significantly lower in this group in comparison to the group of AML patients with a normal karyotype (p = 0.01) in bone marrow cells.